Sharepoint Solutions
PRODUCTS
-
As you aim to bring your advanced therapies to patients in need, partnering to overcome the associated regulatory, manufacturing, and logistical complexities is essential to avoid unnecessary costs and delays.
-
As a critical starting material in the production of many advanced therapies including viral vectors and RNA vaccines, cell and gene therapy research at any scale requires plasmid DNA manufacturing. Our specialists provide custom plasmid production that fits your project specifications. To save time and accelerate your cell and gene therapy programs, we also offer off-the-shelf, premanufactured, High Quality viral vector packaging plasmids.
-
GORE Protein Capture Devices with Protein A utilize a unique membrane composite that provides a binding capacity advantage at high flow rates and improves the speed of purification versus traditional technologies. Designed for drug discovery through clinical applications, they provide significant capacity and speed improvements, with sharp elutions in the purification of antibody based therapies.
-
Accelerate your path to success with NetSuite by leveraging a top 3 NetSuite Partner in the world.
5 star, award-winning support in your corner
Optimize NetSuite for your industry, based on best practices, and get sound recommendations regarding processes and user scenarios based on years of expertise. We help our NetSuite clients and potential clients see what’s possible, set priorities, create a roadmap for accomplishment, and deliver results that matter.
When you choose Sikich, you choose a dedicated team of NetSuite consultants who spent years in a specific industry before they joined us, and who are committed to making a vital contribution to your business.
Get the connected, available and accountable support that your organization deserves by joining the ranks of our highly satisfied clients.
-
Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and emerging contaminants don’t break down easily, making them difficult to remove from our water sources. Newterra offers pre-engineered adsorber filtration systems for effective removal at any flow rate.
WHITE PAPERS AND CASE STUDIES
-
Mobile Research Units Enable Large Volume Screenings
Learn how recruitment and screening of potential patients was made possible for a Phase 3, adult patients, clinical trial by utilizing MRUs to screen large volumes of patients at community events.
-
Alzheimer's Study Involving Home Infusions Exceeds Expectations
Gain insight from this Phase 3 global clinical trial focused on pre-clinical Alzheimer’s Disease where adult patients received one-hour intravenous infusions every month for 4.5 years.
-
Digitalizing Batch Records In Pharmaceutical Production
Pharma manufacturing embraces cutting-edge automation, yet outdated paper-based documentation hinders efficiency and delays batch releases. See how digital solutions can transform compliance.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
The Growth Of Sterile Injectables
Learn why partnering with a manufacturer capable of delivering flexible aseptic fill-finish solutions for any size production run is essential for delivering products to patients safely and efficiently.
-
Are You Leveraging All Of Your Clinical Data?
To develop and execute a successful clinical strategy, trial sponsors must be able to rapidly acquire detailed data insights. Learn how you can better utilize your trial data and achieve greater insights.
-
Selecting A New Sporicidal Disinfectant: What The Cleanroom Manager Needs To Know
This guide helps cleanroom managers evaluate sporicides by efficacy, safety, and compatibility to ensure contamination control without compromising operational integrity.
-
Solving The Silicone Challenge In Pre-Fillable Syringes
Discover a technology platform that is revolutionizing the pre-fillable syringe market by solving the challenge of silicone sensitivity, ensuring stability for sensitive drugs.
-
A Comprehensive Planning Approach For Cancer Antibody
Discover how a clinical-stage biotech company was able to accelerate pathways for development and regulatory review of their first Phase 1 protocol for an immuno-oncology antibody.
-
Navigating The Complexities Of CGTs With Regulatory And CMC Expertise
Review the submission process and CMC expertise which helped a biopharmaceutical company targeting a rare-disease tumor type avoid a clinical hold and advance to phase 1 clinical trials.
-
Development Of A Non-Standard Protein Therapeutic
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
Supporting A Company In Manufacturing The RSM For Treating A Rare Tumour
A clinical-stage oncology company needed a partner to manufacture the RSM. Examine how an optimized RSM manufacturing process helped deliver safe, effective treatment on an accelerated timeline.
NEWS
-
Biden-Harris Administration Announces $94M WIFIA Loan To Upgrade Wastewater Infrastructure In New Lenox, IL3/11/2024
Today, the U.S. Environmental Protection Agency (EPA) announced a $94M Water Infrastructure Finance and Innovation Act (WIFIA) loan to the Village of New Lenox in northeastern Illinois.
-
EGLE Announces $67.1M In MI Clean Water Grants To Help Michigan Communities Upgrade Water Infrastructure, Protect Health And The Environment1/25/2024
Reducing sewage overflows into Lake St. Clair and replacing hazardous lead drinking water service lines in multiple communities are some of the goals of more than $67M in state grants recently awarded to Michigan communities.
-
WRF Seeks Pre-Proposals For High-Priority Utility Research2/6/2025
The Water Research Foundation (WRF) is now accepting pre-proposals for its matching research program, the Tailored Collaboration Program.
-
Moderna Receives Project Award Through BARDA's Rapid Response Partnership Vehicle Consortium To Accelerate Development Of mRNA-Based Pandemic Influenza Vaccine7/2/2024
Moderna, Inc. today announced a project award of $176M through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines.
-
Securing Water Systems Against Cyber-Threats: Idaho Leads With Cyber-Informed Engineering3/6/2025
When it comes to cybersecurity research, the Idaho National Laboratory (INL) and Idaho have a relationship that dates back to the 1990s and was hallmarked in 2019 with the opening of the state-funded Cybercore Integration Center on INL’s Research and Education Campus in Idaho Falls.